Table 3 Comparison of the prevalence of effective treatment at different doses
Time (months) | ≤50 U (n = 43) | 50-100 U (n = 32) | ≥ 100 U (n = 13) | p |
|---|---|---|---|---|
Effective value, % (n) | Effective value, % (n) | Effective value, % (n) | ||
1 | 88.4 (38) | 93.8 (30) | 100.0 (13) | 0.360 |
2 | 100.0 (43) | 100.0 (32) | 100.0 (13) | ___ |
3 | 88.4 (38) | 87.5 (28) | 76.9 (10) | 0.558 |
4 | 76.7 (33) | 65.6 (21) | 76.9 (10) | 0.528 |
5 | 74.4 (32) | 62.5 (20) | 76.9 (10) | 0.459 |
6 | 72.1 (31) | 56.3 (18) | 53.8 (7) | 0.270 |
7 | 65.1 (28) | 53.1 (17) | 46.2 (6) | 0.376 |
8 | 60.5 (26) | 50.0 (16) | 38.5 (5) | 0.337 |
9 | 58.1 (25) | 50.0 (16) | 38.5 (5) | 0.437 |
10 | 58.1 (25) | 46.9 (15) | 30.8 (4) | 0.203 |
11 | 55.8 (24) | 46.9 (15) | 23.1 (3) | 0.116 |
12 | 51.2 (22) | 43.8 (14) | 23.1 (3) | 0.202 |
13 | 48.8 (21) | 37.5 (12) | 15.4 (2) | 0.892 |
14 | 46.5 (20) | 37.5 (12) | 15.4 (2) | 0.128 |